FDA Approved: DEFEROXAMINE — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved Deferoxamine mesylate as a generic product under Original Application by Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Transfusion-dependent
• Iron Overload
• Iron Poisoning

Drugs mentioned

• Deferoxamine (deferoxamine)

Snippet

ORIG AP for DEFEROXAMINE (DEFEROXAMINE MESYLATE)